New bladder treatment aims to stop Cancer's return, spare patients major surgery
NCT ID NCT07464145
Summary
This Phase 3 study is testing a new drug called NDV-01 for people with non-muscle invasive bladder cancer (NMIBC). It aims to see if putting the drug directly into the bladder can prevent the cancer from coming back and stop it from getting worse, which could help patients avoid having their bladder surgically removed. The study will enroll about 393 adults with different risk levels of NMIBC who have had prior treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA BLADDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.